Mesoblast | MSB - Operating Expenses


Mesoblast reported $88.91M in Operating Expenses for its fiscal semester ending in June of 2026.





Operating Expenses Change Date
Avita Medical AUD 28.02M 1.55M Dec/2025
Clinuvel Pharmaceuticals AUD 23.42M 6.49M Dec/2025
Cochlear AUD 914.9M 454.8M Dec/2025
CSL USD 5.7B 2.82B Dec/2025
Pacific Edge NZD 22.5M 2.84M Jun/2026
PYC Therapeutics AUD 33.63M 14.33M Dec/2025
Ramsay Health Care AUD 8.8B 83.5M Dec/2025
Sonic Healthcare AUD 4.23B 2.14B Dec/2024
Starpharma Holdings AUD 11.7M 7.69M Dec/2025
Telix Pharmaceuticals AUD 430.99M 25.59M Jun/2026